Suppr超能文献

凝集素和化学修饰对人血浆纤连蛋白血凝素活性的影响。

Effect of lectins and chemical modification on the hemagglutinin activity of human plasma fibronectin.

作者信息

Vuento M, Salonen E

出版信息

Z Naturforsch C Biosci. 1981 Sep-Oct;36(9-10):863-8.

PMID:7303818
Abstract

Purified human plasma fibronectin has been shown to agglutinate protease-treated red cells [Vuento, Hoppe-Seyler's Z. Physiol. Chem. 360, 1327-1333, (1979)]. The present report shows that the activity is inhibited by low concentrations of lectins and by macromolecular serum factors. Chemical modification of carboxyl groups of fibronectin strongly inhibited the activity, but modification of amino groups of guanidinium groups had little effect on the activity. The results suggest that fibronectin receptors on erythrocyte surface are carbohydrate-containing molecules. Humoral macromolecular factors may control the interaction of fibronectin with cell surfaces. Chemical modification studies indicate that the parts of the fibronectin molecule responsible for the hemagglutinin activity are different from those mediating the binding of fibronectin to collagen.

摘要

纯化的人血浆纤连蛋白已被证明能凝集经蛋白酶处理的红细胞[武恩托,《霍佩-赛勒生理化学杂志》360,1327 - 1333,(1979年)]。本报告表明,该活性受到低浓度凝集素和大分子血清因子的抑制。对纤连蛋白羧基进行化学修饰会强烈抑制该活性,但对氨基或胍基进行修饰对活性影响不大。结果表明,红细胞表面的纤连蛋白受体是含碳水化合物的分子。体液中的大分子因子可能控制纤连蛋白与细胞表面的相互作用。化学修饰研究表明,纤连蛋白分子中负责血凝素活性的部分与介导纤连蛋白与胶原蛋白结合的部分不同。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验